ASTELLAS PHARMA NUF

2000 LILLESTRØM

Finances

Share Ownership

Return on Equity

N/A

Current Ratio

0,99

Debt-to-Equity Ratio

N/A

Key figures (NOK)	2022	2021	2020	2019
Revenue	39 613 000	49 035 000	51 717 000	48 372 000
Net Income	1 252 000	1 170 000	714 000	1 041 000
Total Assets	33 827 000	14 813 000	11 948 000	11 018 000
Total Equity	0	0	0	0

Income (NOK)	2022	2021	2020	2019
Revenue	39 613 000	49 035 000	51 717 000	48 372 000
Expenditure	37 688 000	45 707 000	49 878 000	46 530 000
Operating Profit	1 925 000	3 328 000	1 839 000	1 842 000
Financial Income	583 000	−2 000	1 412 000	364 000
Financial Costs	622 000	973 000	780 000	357 000
Financial Balance	−39 000	−975 000	632 000	7 000
Earnings Before Tax	1 886 000	2 354 000	2 470 000	1 849 000
Tax	635 000	1 183 000	1 757 000	808 000
Net Income	1 252 000	1 170 000	714 000	1 041 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	316 000	1 033 000	540 000	710 000
Total Current Assets	33 511 000	13 780 000	11 408 000	10 309 000
Total Assets	33 827 000	14 813 000	11 948 000	11 018 000
Total Retained Equity	0	0	0	0
Total Equity	0	0	0	0
Total Long-Term Debt	0	0	8 000	12 000
Total Current Debt	33 827 000	14 813 000	11 940 000	11 007 000
Total Equity and Debt	33 827 000	14 813 000	11 948 000	11 018 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	0	0	0	0
Other Income	39 613 000	49 035 000	51 717 000	48 372 000
Revenue	39 613 000	49 035 000	51 717 000	48 372 000
Cost of Goods Sold	0	0	0	0
Salary Costs	23 357 000	26 912 000	27 853 000	25 554 000
Depreciation	186 000	169 000	162 000	124 000
Impairment	0	0	0	0
Expenditure	37 688 000	45 707 000	49 878 000	46 530 000
Operating Profit	1 925 000	3 328 000	1 839 000	1 842 000
Financial Income	583 000	−2 000	1 412 000	364 000
Financial Costs	622 000	973 000	780 000	357 000
Financial Balance	−39 000	−975 000	632 000	7 000
Dividends	0	0	0	0
Net Income	1 252 000	1 170 000	714 000	1 041 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	17 000	553 000	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	299 000	480 000	540 000	710 000
Total Tangible Assets	299 000	480 000	540 000	710 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	316 000	1 033 000	540 000	710 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	8 849 000	3 365 000	1 941 000	1 796 000
Total Current Assets	33 511 000	13 780 000	11 408 000	10 309 000
Total Assets	33 827 000	14 813 000	11 948 000	11 018 000
Total Equity	0	0	0	0
Short-Term Group Debt	0	33 000	83 000	0
Total Long-Term Debt	0	0	8 000	12 000
Creditors	25 412 000	701 000	486 000	2 036 000
Unpaid Taxes	930 000	1 287 000	1 166 000	1 156 000
Dividends	0	0	0	0
Other Current Debt	6 395 000	10 054 000	8 066 000	6 559 000
Total Current Debt	33 827 000	14 813 000	11 940 000	11 007 000
Total Equity and Debt	33 827 000	14 813 000	11 948 000	11 018 000

Financial indicators	2022	2021	2020	2019
Return on Equity	-	-	-	-
Debt-to-Equity Ratio	-	-	-	-
Operating Profit Margin	4,86 %	6,79 %	3,56 %	3,81 %
Current Ratio	0,99	0,93	0,96	0,94
Quick Ratio	0,99	0,93	0,96	0,94
Equity Ratio	0	0	0	0
Gross Profit Margin	100 %	100 %	100 %	100 %